SEK 0.04
(-1.39%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 231.97 Million SEK | 11.86% |
2022 | 207.38 Million SEK | -55.56% |
2021 | 466.63 Million SEK | 13.2% |
2020 | 412.23 Million SEK | 10.1% |
2019 | 374.4 Million SEK | -30.55% |
2018 | 539.06 Million SEK | 2830.2% |
2017 | 18.39 Million SEK | 9.11% |
2016 | 16.86 Million SEK | 20.76% |
2015 | 13.96 Million SEK | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 158.97 Million SEK | -8.68% |
2024 Q1 | 174.07 Million SEK | -24.96% |
2023 Q1 | 188.41 Million SEK | -9.15% |
2023 FY | 231.97 Million SEK | 11.86% |
2023 Q4 | 231.97 Million SEK | -18.66% |
2023 Q3 | 285.18 Million SEK | 58.84% |
2023 Q2 | 179.54 Million SEK | -4.71% |
2022 Q2 | 330.12 Million SEK | -17.83% |
2022 Q4 | 207.38 Million SEK | -23.58% |
2022 Q1 | 401.73 Million SEK | -13.91% |
2022 FY | 207.38 Million SEK | -55.56% |
2022 Q3 | 271.38 Million SEK | -17.79% |
2021 Q4 | 466.63 Million SEK | -12.57% |
2021 Q2 | 600.22 Million SEK | 68.68% |
2021 Q1 | 355.84 Million SEK | -13.68% |
2021 FY | 466.63 Million SEK | 13.2% |
2021 Q3 | 533.72 Million SEK | -11.08% |
2020 Q4 | 412.23 Million SEK | -12.63% |
2020 Q3 | 471.81 Million SEK | -8.69% |
2020 Q2 | 516.74 Million SEK | 63.3% |
2020 Q1 | 316.43 Million SEK | -15.48% |
2020 FY | 412.23 Million SEK | 10.1% |
2019 Q3 | 421.78 Million SEK | -8.28% |
2019 FY | 374.4 Million SEK | -30.55% |
2019 Q2 | 459.84 Million SEK | -7.77% |
2019 Q4 | 374.4 Million SEK | -11.23% |
2019 Q1 | 498.59 Million SEK | -7.51% |
2018 Q1 | - SEK | -100.0% |
2018 FY | 539.06 Million SEK | 2830.2% |
2018 Q4 | 539.06 Million SEK | 568.19% |
2018 Q3 | 80.67 Million SEK | -27.37% |
2018 Q2 | 111.07 Million SEK | 0.0% |
2017 Q1 | - SEK | 0.0% |
2017 FY | 18.39 Million SEK | 9.11% |
2017 Q4 | 18.39 Million SEK | 0.0% |
2016 FY | 16.86 Million SEK | 20.76% |
2015 FY | 13.96 Million SEK | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AddLife AB (publ) | 12.74 Billion SEK | 98.18% |
Biotage AB (publ) | 4.93 Billion SEK | 95.296% |
Bonesupport Holding AB (publ) | 688.81 Million SEK | 66.323% |
Doxa AB (publ) | 3.75 Billion SEK | 93.822% |
Elekta AB (publ) | 31.41 Billion SEK | 99.262% |
iZafe Group AB (publ) | 34.61 Million SEK | -570.18% |
Ortivus AB (publ) | 72.7 Million SEK | -219.06% |
Ortivus AB (publ) | 72.7 Million SEK | -219.06% |
S2Medical AB (publ) | 21.4 Million SEK | -983.625% |
Synsam AB (publ) | 8.03 Billion SEK | 97.113% |